IMMU-29. LAG-3 COMPENSATES TIM-3 DOWN-REGULATION IN A HUMAN GLIOBLASTOMA MODEL

INTRODUCTION: There are a few alternatives treatments beside the standard care for glioblastomas, one of them is adoptive cell therapy; our group has shown promising preliminary results with a dendritic cell-based vaccine that has being tested in first-in-human clinical trials. Checkpoint inhibitors...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Ogando-Rivas, Elizabeth, Castillo-Caro, Paul, Jones, Noah, Dechkovskaia, Anjelika, Yang, Changlin, Mitchell, Duane
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2020
Assuntos:
Immunology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651664/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.459
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares